Table of Contents
<< Previous Issue | Jun 2012 (Vol: 2012, Issue: 6) | Next Issue >> |
- Section: Features
-
Consolidation and Differentiation: Key Drivers of Change in the Global Pharmaceutical Manufacturing Industry
- Section: Licensing
-
GSK’s Stiefel Laboratories Acquires Welichem Biotech’s Mid-Stage Psoriasis and Atopic Dermatitis Drug
-
Baxter Pursues Haemophilia B Gene Therapy with Chatham Therapeutics Collaboration
-
GSK Strengthens its Dermatology Business with Acquisition of Basilea’s Toctino®
- Section: Mergers & Acquisitions
-
UCB Accesses Brazilian Market by Acquiring Majority Stake in Meizler Biopharma
-
Newron Moves to Acquire Swedish Neurogenesis Company NeuroNova
-
Upsher-Smith to Take Over CNS Partner Proximagen
- Section: Research & Development
-
Genentech Becomes Ensemble Therapeutics’ Third Big Pharma Collaborator on Macrocyclic Drug Discovery
-
Forest Gains Takeover Option in Antibiotic Development Deal with Nabriva Therapeutics
-
Genmab’s DuoBody™ Technology Gains Validation with Novartis Collaboration
-
Merck KGaA Ventures into Biosimilars in Collaboration with Dr. Reddy’s
-
Genentech and AC Immune Partner Again in Alzheimer’s Disease
-
Merck & Co. Forays into Biologic-Drug Conjugates in Collaboration with Ambrx